Lab-grown mini-brains to find treatments for autism
An Integrated Drug Discovery Platform for Neurodevelopmental Disorders Using Standardized Self-Organizing Human Cerebroids
['FUNDING_SBIR_2'] · RUMI SCIENTIFIC, INC. · NIH-11081787
This project uses patient-derived mini-brains and artificial intelligence to look for drugs that could help people with certain genetic forms of autism.
Quick facts
| Phase | ['FUNDING_SBIR_2'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | RUMI SCIENTIFIC, INC. (nih funded) |
| Locations | 1 site (New York, UNITED STATES) |
| Trial ID | NIH-11081787 on ClinicalTrials.gov |
What this research studies
The team will grow standardized, self-organizing forebrain "cerebroids" from patient-derived cells to model how neurons form and connect. They will compare cerebroids made from cells with five known autism-linked gene mutations (ADNP, DDX3X, FOXP1, FOXG1, SHANK3) to establish what normal and disease patterns look like. An AI system will scan these models to detect subtle differences in neuronal networks. The platform is designed to test many molecules rapidly to find candidates that normalize disease-related features.
Who could benefit from this research
Good fit: People (or families) with autism linked to one of the specified single-gene mutations or who can provide biological samples for genetic testing are the most likely candidates to contribute samples or participate.
Not a fit: People with autism that is not tied to the specific genes studied, or those who cannot provide biological samples, may not directly benefit from this project.
Why it matters
Potential benefit: If successful, this could uncover new drug candidates that correct neural network abnormalities in some monogenic forms of autism.
How similar studies have performed: Other groups using brain organoids have revealed disease features and suggested drug leads, but this standardized, AI-driven cerebroid drug-screening approach is relatively new.
Where this research is happening
New York, UNITED STATES
- RUMI SCIENTIFIC, INC. — New York, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ETOC, FRED — RUMI SCIENTIFIC, INC.
- Study coordinator: ETOC, FRED
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Autistic Disorder